My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Jindal Drilling & Industries standalone net profit declines 3.66% in the June 2016 quarter

Jindal Drilling & Industries standalone net profit declines 3.66% in the June 2016 quarter

Sep 14,2016

Net profit of Jindal Drilling & Industries declined 3.66% to Rs 9.48 crore in the quarter ended June 2016 as against Rs 9.84 crore during the previous quarter ended June 2015. Sales rose 11.24% to Rs 92.66 crore in the quarter ended June 2016 as against Rs 83.30 crore during the previous quarter ended June 2015.

ParticularsQuarter Ended
n++Jun. 2016Jun. 2015% Var.
Sales92.6683.3011
OPM %9.8912.74-
PBDT14.5518.68-22
PBT12.0915.01-19
NP9.489.84-4

Powered by Capital Market - Live News

Rich Universe Network reports standalone nil net profit/loss in the March 2017 quarter
May 26,2017

Rich Universe Network reported no net profit/loss in the quarter ended March 2017 as against net loss of Rs 0.05 crore during the previous quarter ended March 2016. Sales declined 7.02% to Rs 0.53 crore in the quarter ended March 2017 as against Rs 0.57 crore during the previous quarter ended March 2016.

For the full year,net profit remain constant at Rs 0.01 crore in the year ended March 2017 and also during the previous year ended March 2016. Sales declined 29.00% to Rs 2.13 crore in the year ended March 2017 as against Rs 3.00 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear Endedn++Mar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var. Sales0.530.57 -7 2.133.00 -29 OPM %0-8.77 -0.470.33 - PBDT0-0.05 100 0.010.01 0 PBT0-0.05 100 0.010.01 0 NP0-0.05 100 0.010.01 0

Powered by Capital Market - Live News

West Coast Paper Mills standalone net profit rises 513.30% in the March 2017 quarter
May 26,2017

Net profit of West Coast Paper Mills rose 513.30% to Rs 50.72 crore in the quarter ended March 2017 as against Rs 8.27 crore during the previous quarter ended March 2016. Sales rose 4.02% to Rs 473.30 crore in the quarter ended March 2017 as against Rs 455.03 crore during the previous quarter ended March 2016.

For the full year,net profit reported to Rs 128.50 crore in the year ended March 2017 as against net loss of Rs 0.47 crore during the previous year ended March 2016. Sales rose 4.01% to Rs 1762.91 crore in the year ended March 2017 as against Rs 1694.99 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear Endedn++Mar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var. Sales473.30455.03 4 1762.911694.99 4 OPM %20.4314.57 -19.1614.72 - PBDT92.2051.07 81 288.65181.39 59 PBT63.3722.63 180 177.8867.03 165 NP50.728.27 513 128.50-0.47 LP

Powered by Capital Market - Live News

Bosch standalone net profit declines 10.22% in the March 2017 quarter
May 26,2017

Net profit of Bosch declined 10.22% to Rs 440.47 crore in the quarter ended March 2017 as against Rs 490.60 crore during the previous quarter ended March 2016. Sales rose 6.01% to Rs 2528.83 crore in the quarter ended March 2017 as against Rs 2385.52 crore during the previous quarter ended March 2016.

For the full year,net profit rose 13.70% to Rs 1741.12 crore in the year ended March 2017 as against Rs 1531.34 crore during the previous year ended March 2016. Sales rose 7.44% to Rs 10175.94 crore in the year ended March 2017 as against Rs 9471.62 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear Endedn++Mar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var. Sales2528.832385.52 6 10175.949471.62 7 OPM %27.8323.82 -19.2619.83 - PBDT811.53757.82 7 2847.652487.88 14 PBT662.36625.85 6 2391.422101.44 14 NP440.47490.60 -10 1741.121531.34 14

Powered by Capital Market - Live News

Cipla standalone net profit rises 181.39% in the March 2017 quarter
May 26,2017

Net profit of Cipla rose 181.39% to Rs 25.86 crore in the quarter ended March 2017 as against Rs 9.19 crore during the previous quarter ended March 2016. Sales declined 4.19% to Rs 2608.51 crore in the quarter ended March 2017 as against Rs 2722.64 crore during the previous quarter ended March 2016.

For the full year,net profit declined 33.33% to Rs 974.94 crore in the year ended March 2017 as against Rs 1462.30 crore during the previous year ended March 2016. Sales declined 10.07% to Rs 10637.08 crore in the year ended March 2017 as against Rs 11828.74 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear Endedn++Mar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var. Sales2608.512722.64 -4 10637.0811828.74 -10 OPM %7.013.99 -15.0117.36 - PBDT209.30139.67 50 1686.912186.66 -23 PBT84.1320.62 308 1186.941743.97 -32 NP25.869.19 181 974.941462.30 -33

Powered by Capital Market - Live News

Britannia Industries standalone net profit rises 2.54% in the March 2017 quarter
May 26,2017

Net profit of Britannia Industries rose 2.54% to Rs 196.73 crore in the quarter ended March 2017 as against Rs 191.86 crore during the previous quarter ended March 2016. Sales rose 6.79% to Rs 2067.01 crore in the quarter ended March 2017 as against Rs 1935.67 crore during the previous quarter ended March 2016.

For the full year,net profit rose 10.53% to Rs 843.69 crore in the year ended March 2017 as against Rs 763.31 crore during the previous year ended March 2016. Sales rose 8.62% to Rs 8311.53 crore in the year ended March 2017 as against Rs 7651.64 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear Endedn++Mar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var. Sales2067.011935.67 7 8311.537651.64 9 OPM %13.8413.78 -14.4914.62 - PBDT318.34301.32 6 1347.591236.92 9 PBT291.51277.33 5 1251.161149.13 9 NP196.73191.86 3 843.69763.31 11

Powered by Capital Market - Live News

Oil Country Tubular reports standalone net loss of Rs 49.61 crore in the March 2017 quarter
May 26,2017

Net loss of Oil Country Tubular reported to Rs 49.61 crore in the quarter ended March 2017 as against net profit of Rs 6.47 crore during the previous quarter ended March 2016. Sales declined 96.47% to Rs 1.97 crore in the quarter ended March 2017 as against Rs 55.80 crore during the previous quarter ended March 2016.

For the full year,net loss reported to Rs 83.96 crore in the year ended March 2017 as against net loss of Rs 6.60 crore during the previous year ended March 2016. Sales declined 95.22% to Rs 6.59 crore in the year ended March 2017 as against Rs 137.88 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear Endedn++Mar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var. Sales1.9755.80 -96 6.59137.88 -95 OPM %-255.8418.85 --240.9711.59 - PBDT-9.438.81 PL -28.7810.73 PL PBT-15.030.77 PL -51.18-12.50 -309 NP-49.616.47 PL -83.96-6.60 -1172

Powered by Capital Market - Live News

No dearth of coal at Rajmahal OCP to supply Kahalgaon and Farakka Power Stations of NTPC
May 26,2017

Rajmahal Opencast Project of Eastern Coalfields Limited (ECL), a subsidiary of Coal India Limited, has set a target of 17 Million Tonne (MT) coal production during 2017-18 at its optimum capacity. Rajmahal OCP produced 14.43 MTs of coal during 2016-17.

With the issue of shifting Bhadotola village being solved in stages with the help of Jharkhand State Government, Rajmahal OCP is fully geared up to supply coal to Kahalgaon and Farakka Plants of NTPC throughout the year. At present 25,000 tonnes to 30,000 tonnes daily production will continue till June 2017 end. From July 2017 onwards further 7 MTs of coal will be made available at Dahernangi patch.

Further, more than 20 MTs additional coal will be made available from Bhadotola which will help Rajmahal OCP to produce 17 MTs during the current fiscal with continued law and order support from Jharkhand Government in shifting Bhadotola village.

At present, the demand of Farakka and Kahalgaon is met by supplying 25,000 tonnes to 30,000 tonnes coal from Rajmahal MGR and remaining from Raniganj Coalfield of ECL through rail which continues during monsoon period also. There will be no dearth of coal at Rajmahal OCP to supply Kahalgaon and Farakka Power Stations of NTPC.

Powered by Capital Market - Live News

ITC hits record high
May 26,2017

The result was announced during market hours today, 26 May 2017.

Meanwhile, the S&P BSE Sensex was up 286.83 points or 0.93% at 31,036.86.

On the BSE, 22.07 lakh shares were traded on the counter so far as against the average daily volumes of 11.54 lakh shares in the past one quarter. The stock had hit a high of Rs 313.40 so far during the day, which is a record high. The stock hit a low of Rs 300 so far during the day. The stock had hit a 52-week low of Rs 222.05 on 26 December 2016.

The stock had outperformed the market over the past one month till 25 May 2017, advancing 6.58% compared with the Sensexs 2.69% rise. The scrip had also outperformed the market over the past one quarter, gaining 12.8% as against the Sensexs 6.43% rise.

The large-cap company has equity capital of Rs 1214.74. Face value per share is Rs 1.

ITCs board recommended a dividend of Rs 4.75 per share for the year ended March 2017.

ITC is a diversified company, with presence in cigarettes, hotels, paperboards & specialty papers, packaging, agri-business, packaged foods & confectionery, information technology, branded apparel, personal care, stationery and other FMCG products. ITC is a market leader in cigarettes.

Powered by Capital Market - Live News

Ujaas Energy shines after bagging order
May 26,2017

The announcement was made during market hours today, 26 May 2017.

Meanwhile, the S&P Sensex was up 264.51 points or 0.86% at 31,014.54. The S&P BSE Small-cap index was up 224.41 points, or 1.51% at 15,073.14.

On the BSE, 1.75 lakh shares were traded on the counter so far as against the average daily volumes of 2.5 lakh shares in the past one quarter. The stock had hit a high of Rs 36 and a low of Rs 33.70 so far during the day.

The stock had hit a record high of Rs 52.25 on 16 December 2016 and a 52-week low of Rs 19.40 on 29 September 2016. The stock had underperformed the market over the past one month till 25 May 2017, dropping 9.04% compared with 2.69% rise in the Sensex. The scrip had also underperformed the market in past one quarter, declining 4.4% as against Sensexs 6.43% rise.

The small-cap company has equity capital of Rs 20 crore. Face value per share is Re 1.

Ujaas Energy received letter of intent from Arunachal Pradesh Energy Development Agency for design, supply, installation, testing and commissioning of 200 kilowatt peak (kWp) grid connected solar photovoltaic plant at the state assembly building in Itanagar, Arunachal Pradesh.

Ujaas Energys net profit surged 266.5% to Rs 8.54 crore on 113.8% growth in net sales to Rs 97.66 crore in Q3 December 2016 over Q3 December 2015.

Ujaas Energy is engaged in the design of various products and solutions for producing clean energy.

Powered by Capital Market - Live News

Sun Pharma extends recent slide
May 26,2017

Meanwhile, the S&P BSE Sensex was up 272.76 points or 0.89% at 31,022.79.

On the BSE, 9.96 lakh shares were traded on the counter so far as against the average daily volumes of 3.75 lakh shares in the past one quarter. The stock had hit a high of Rs 598.45 and a low of Rs 568.20 so far during the day.

The stock had hit a 52-week high of Rs 854.50 on 5 August 2016 and a 52-week low of Rs 572.40 on 9 November 2016. It had underperformed the market over the past one month till 25 May 2017, sliding 7.89% compared with the Sensexs 2.69% rise. The scrip had also underperformed the market over the past one quarter, declining 12.38% as against the Sensexs 6.43% rise.

The large-cap company has equity capital of Rs 239.93 crore. Face value per share is Rs 1.

Shares of Sun Pharmaceutical Industries (Sun Pharma) have declined 12.48% in six trading sessions to its ruling market price, from its closing of Rs 653.90 on 18 May 2017, ahead of the companys Q4 March 2017 earnings scheduled today, 26 May 2017.

Also, weak quarterly earnings from the companys US subsidiary Taro Pharmaceutical Industries (Taro) announced on 22 May 2017, dampened investors sentiment in Sun Pharma.

Taros net profit fell 27.82% to $83 million on 25.9% decrease in net sales to $196.40 million in Q4 March 2017 over Q4 March 2016. The drop in net sales is due to continuing increased competition and the challenging pricing environment.

On a consolidated basis, Sun Pharmaceuticals Industries net profit declined 11.2% to Rs 1721.85 crore on 8.4% rise in net sales to Rs 7683.24 crore in Q3 December 2016 over Q3 December 2015.

Sun Pharma is a specialty generic pharmaceutical company and Indias top pharmaceutical company.

Powered by Capital Market - Live News

3M India jumps after reporting good Q4 earnings
May 26,2017

The result was announced during market hours today, 26 May 2017.

Meanwhile, the S&P BSE Sensex was up 256.70 points, or 0.83% at 31,006.73.

High volumes were witnessed on the counter. On the BSE, 2,357 shares were traded on the counter so far as against the average daily volumes of 408 shares in the past one quarter. The stock had hit a high of Rs 14,297.35 and a low of Rs 13,274.30 so far during the day.

The stock had hit a record high of Rs 15,200 on 26 July 2016 and a 52-week low of Rs 10,055 on 27 December 2016. The stock had outperformed the market over the past one month till 25 May 2017, advancing 13.5% compared with the Sensexs 2.69% rise. The scrip had also outperformed the market over the past one quarter advancing 17.68% as against the Sensexs 6.43% rise.

The large-cap company has equity capital of Rs 11.27 crore. Face value per share is Rs 10.

3M India provides industrial, automotive, electrical, telecom and safety products.

Powered by Capital Market - Live News

HeidelbergCement India hardens after good Q4 results
May 26,2017

The result was announced after market hours yesterday, 25 May 2017.

The stock had risen 3.49% to Rs 124.70 yesterday, 25 May 2017 ahead of the results.

Meanwhile, the S&P BSE Sensex was up 245.97 points or 0.8% at 30,996. The S&P Small-Cap index was up 209.96 points or 1.41% at 15,058.69.

On the BSE, 62,676 shares were traded in the counter so far as against average daily volume of 69,326 shares in the past one quarter.

The stock had hit a high of Rs 130.65 and a low of Rs 126.50 so far during the day. The stock had hit a 52-week high of Rs 150.55 on 28 October 2016. The stock had hit a 52-week low of Rs 94.25 on 25 May 2016. The stock had underperformed the market over the past one month till 25 May 2017, dropping 7.53% compared with 2.69% rise in the Sensex. The scrip, had, however, outperformed the market in past one quarter, gaining 7.36% as against Sensexs 6.43% rise.

The small-cap cement manufacturing company has equity capital of Rs 226.62 crore. Face value per share is Rs 10.

HeidelbergCement India said that the board of directors recommended a dividend of Rs 2 per share for the financial year ended 31 March 2017 (FY 2017).

HeidelbergCement India is a subsidiary of HeidelbergCement Group, Germany. The company has its operations in Central India at Damoh (Madhya Pradesh), Jhansi (Uttar Pradesh) and in Southern India at Ammasandra (Karnataka).

Powered by Capital Market - Live News

HeidelbergCement India hardens after strong Q4 results
May 26,2017

The result was announced after market hours yesterday, 25 May 2017.

The stock had risen 3.49% to Rs 124.70 yesterday, 25 May 2017 ahead of the results.

Meanwhile, the S&P BSE Sensex was up 245.97 points or 0.8% at 30,996. The S&P Small-Cap index was up 209.96 points or 1.41% at 15,058.69.

On the BSE, 62,676 shares were traded in the counter so far as against average daily volume of 69,326 shares in the past one quarter.

The stock had hit a high of Rs 130.65 and a low of Rs 126.50 so far during the day. The stock had hit a 52-week high of Rs 150.55 on 28 October 2016. The stock had hit a 52-week low of Rs 94.25 on 25 May 2016. The stock had underperformed the market over the past one month till 25 May 2017, dropping 7.53% compared with 2.69% rise in the Sensex. The scrip, had, however, outperformed the market in past one quarter, gaining 7.36% as against Sensexs 6.43% rise.

The small-cap cement manufacturing company has equity capital of Rs 226.62 crore. Face value per share is Rs 10.

HeidelbergCement India said that the board of directors recommended a dividend of Rs 2 per share for the financial year ended 31 March 2017 (FY 2017).

HeidelbergCement India is a subsidiary of HeidelbergCement Group, Germany. The company has its operations in Central India at Damoh (Madhya Pradesh), Jhansi (Uttar Pradesh) and in Southern India at Ammasandra (Karnataka).

Powered by Capital Market - Live News

Govt. to set up state cancer institutes each costing Rs. 100 cr: Anupriya Patel, MoS, Health & Family Welfare
May 26,2017

Government has recently approved a scheme for enhancing the Tertiary Care Cancer facilities in the country under NPCDCS to grant financial assistance to 20 State Cancer Institutes and 50 Tertiary Cancer Care Centres in different parts of the country, Ms Anupriya Patel, Minister of State for Health & Family Welfare said at an ASSOCHAM event.

The prevalence of hypothyroidism in India is 11%, compared to only 2% in the United Kingdom and 4.6% in the United States of America. Compared with coastal cities like Mumbai, Goa and Chennai, cities located inland like Kolkata, Delhi, Ahmadabad, Bangalore and Hyderabad have a higher prevalence,n++ said Ms Anupriya Patel.

n++Todays India is a young India, where people are willing to work hard with an assurance of being masters of their own destiny. I would like to mention here that India is a signatory to the 2030 agenda for Sustainable Development and is committed to achieve the SDGs including SDG-3 to Ensure healthy lives and promote well-being for all at all ages. The new National Health Policy, 2017 which got approval by the union cabinet recently, envisages to attain the highest possible level of good health and well-being, through a preventive and promotive health care orientation in all developmental policies, and universal access to good quality health care services without anyone having to face financial hardship. This would be achieved through increasing access, improving quality and lowering the cost of healthcare delivery.

The policy, while supporting the need for moving in the direction of a right based approach to healthcare is conscious of the fact that threshold levels of finances and infrastructure is a precondition for an enabling environment, to ensure that the poorest of the poor stand to gain the maximum and are not embroiled in legalities. The policy therefore advocates a progressively incremental assurance based approach, with assured funding to create an enabling environment for realizing health care as a right in the future,n++ said Ms Anupriya Patel.

She further said that currently, women in India, like in other South East Asian countries, face numerous health issues, which ultimately affect their aggregate economic output. We all know that women are pivotal contributors to society in their roles as mothers, sisters, family members, and as socially responsible citizens. Addressing the gender, class or ethnic disparities that exist in healthcare and improving the health outcome, can contribute to women empowerment and socio-economic gain.

n++Between 30-50% of cancers can currently be prevented. This can be accomplished by avoiding risk factors and implementing existing evidence-based prevention strategies. Many cancers have a high chance of cure if diagnosed early and treated adequately. So, the key to survival is prevention, early detection, and proper cure which are possible only with proper awareness among people. Not only the Government, but also private players and NGOs have a great role in creating awareness on the preventive care and symptoms of these diseases. Cancer burden can thus be reduced through early detection and management,n++ added the minister.

n++Determining the goals of treatment and palliative care is an important first step, and health services should be integrated and people-centred. The primary goal is generally to cure cancer or to considerably prolong life. Improving the patients quality of life is also an important goal. This can be achieved by supportive or palliative care and psycho-social support,n++ further said Ms Patel.

Awareness for prevention of cancer and early detection of cancer is being carried out at all levels through NCD clinics at Districts & CHC levels. However higher level facilities for Surgery, chemotherapy & supportive care are available only at District Hospitals. I am told that 388 district NCD clinics and 2115 CHC NCD clinics are functional in the country as on March 2017, said Ms. Patel.

In India, million people suffer from thyroid diseases. There is a high burden of thyroid disorders in India due to endemic iodine deficiency and scarcity of proper therapeutic resources. Thyroid disorders are more common in women than men with the prevalence of 664% and 33.6% respectively, reveals the ASSOCHAM-Turacoz joint paper coinciding with the n++World Thyroid Dayn++ (May 25) noted.

Thyroid disorder is another area affecting womens health. Common manifestations of thyroid disease in women reportedly include hypothyroidism, hyperthyroidism, and thyroid cancers. Hypothyroidism and hyperthyroidism are about 10 times more prevalent in women than in men. Unfortunately, awareness about the disease and its diagnosis remain shockingly low and there is a pressing need to reach out and make women aware of the causes, symptoms, treatment and importance of screening for thyroid problems.

Powered by Capital Market - Live News

Volumes jump at Swelect Energy Systems counter
May 26,2017

Swelect Energy Systems clocked volume of 1.28 lakh shares by 13:55 IST on BSE, a 115.02-times surge over two-week average daily volume of 1,000 shares. The stock zoomed by 20% upper circuit level at Rs 421.35 after the company reported net profit of Rs 13 crore in Q4 March 2017, compared with net loss of Rs 1.04 crore in Q4 March 2016. Total income rose 95.67% to Rs 91.75 crore in Q4 March 2017 over Q4 March 2016.

Healthcare Global Enterprises notched up volume of 2.52 lakh shares, a 96.13-fold surge over two-week average daily volume of 3,000 shares. The stock lost 0.67% at Rs 251.05.

Marico saw volume of 31.67 lakh shares, a 33.11-fold surge over two-week average daily volume of 96,000 shares. The stock was down 0.1% at Rs 314.85.

Banco Products (India) clocked volume of 18.73 lakh shares, a 24.25-fold surge over two-week average daily volume of 77,000 shares. The stock advanced 3.76% at Rs 225.

Sequent Scientific saw volume of 10.41 lakh shares, a 19.3-fold rise over two-week average daily volume of 54,000 shares. The stock was up 3.11% at Rs 116.

Powered by Capital Market - Live News